Clinical and Patient-reported Outcomes After Total Wrist Arthroplasty and Total Wrist Arthrodesis
1 other identifier
observational
51
0 countries
N/A
Brief Summary
The wrist is often considered to be the fundament of the hand. Patients with a destroyed wrist joint caused by osteoarthritis or rheumatoid arthritis may suffer from pain and functional disabilities with impaired life quality. The traditional surgical solution for advanced wrist arthritis is a total wrist fusion (TWF). Although TWF creates a stable wrist with minimal pain, the prize is the joint motion. Total wrist arthroplasty (TWA) is a motion-preserving alternative, but has failed to achieve the widespread use of other joint replacement procedures. TWA is more costly and technically demanding than TWF, and also associated with more complications. In addition, there is no consensus regarding the functional benefit of a TWA compared to TWF since prospective, comparative studies are missing. Aim: The purpose of this prospective cohort study was to compare functional outcome and activity limitations up to two years after surgery with TWA or TWF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedFirst Submitted
Initial submission to the registry
December 28, 2022
CompletedFirst Posted
Study publicly available on registry
January 23, 2023
CompletedJanuary 23, 2023
December 1, 2022
5 years
December 28, 2022
January 11, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Patient-Rated Wrist Evaluation (PRWE) at 24 months
The PRWE is a self-reported questionnaire that includes 15 questions, divided into two subscales assessing pain (5 items) and function (10 items, 6 concerning specific tasks and 4 the ability to perform daily activities) over the past week. The questions are scored on a 10-point ordered categorical scale, ranging from no pain or no difficulty (0 points), to worst pain or unable to do (10 points). The total score of the subscales pain (sum of 5 items) and function (sum of 10 items divided by 2) ranges from 0 to 50. The maximum total score of PRWE is 100 and represents the worst disability, whereas 0 represents no disability.
Up to 24 months
Secondary Outcomes (3)
Visual Analoge Scale (VAS) pain at rest and on load
Up to 24 months
Grip strength
Up to 24 months
Disability of the Hand, Shoulder and Arm (DASH)
Up to 24 months
Other Outcomes (1)
Radiographic evaluation
Up to 24 months
Study Arms (2)
Total Wrist Fusion
Patients with end-stage wrist arthritis treated with total wrist fusion.
Total Wrist Arthroplasty
Patients with end-stage wrist arthritis treated with total wrist arthroplasty of the fourth generation
Interventions
Two different surgical interventions for treatment of end-stage arthritis are compared
Eligibility Criteria
Patients seeking at one hand surgical department with wrist end-stage arthritis and planned for surgery with TWF or TWA were invited to participate in this study. The indications for either a TWF or a TWA at our department are: 1) severe wrist pain and functional disabilities, and 2) radiological evidence of end-stage arthritis, where other options such as proximal row carpectomy or partial arthrodesis are ruled out, and/or 3) the patient had undergone previous surgical procedure/s such as wrist arthroscopy, proximal row carpectomy or partial arthrodesis, but with insufficient results.
You may qualify if:
- Age 18 or older
- Both radoiocarpal and mid carpal arthritis due to osteoarthritis, inflammatory arthritis (such as rheumatoid/psoriasis arthritis), Kienböck's disease
You may not qualify if:
- Wrist problems due to hypermobility or cerebral palsy
- Severe cognitive disorder and unable to fill in questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 28, 2022
First Posted
January 23, 2023
Study Start
March 1, 2015
Primary Completion
February 28, 2020
Study Completion
February 28, 2022
Last Updated
January 23, 2023
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share